Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
445
datasets available to search
ShareScore release 0.9.0
Dataset results
445 results for “diabetic retinopathy”
HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia
ClinicalTrials.gov study NCT04424290. IPD Sharing: NO. Countries: 2. Publications: 1.
Avastin for PDR (Proliferative Diabetic Retinopathy)
ClinicalTrials.gov study NCT01270542. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Diabetic Retinopathy Candesartan Trials
ClinicalTrials.gov study NCT00252733. IPD Sharing: Not stated. Countries: 2. Publications: 5.
Detection and Classification of Diabetic Retinopathy From Posterior Pole Images With A Deep Learning Model
ClinicalTrials.gov study NCT04805541. IPD Sharing: NO. Countries: 1. Publications: 2.
Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy
ClinicalTrials.gov study NCT02753400. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Data from: Systematic review on barriers and enablers for access to diabetic retinopathy screening services in different income settings
Background: Diabetic retinopathy (DR) can lead to visual impairment and blindness if not detected and treated in time. Knowing the barriers/enablers in advance in contrasting different country income settings may accelerate development of a successful DR screening (DRS) program. This would be especially applicable in the low-income settings with the rising prevalence of DR. Objectives: The aim of this systematic review is to identify and contrast the barriers/enablers to DRS for different contexts using both consumers i.e., people with diabetes (PwDM) and provider perspectives and system level factors in different country income settings. Methods: We searched MEDLINE, Embase, CENTRAL in the Cochrane Library from the databases start date to December 2018. We included the studies reported on barriers and enablers to access DRS services based at health care facilities. We categorised and synthesized themes related to the consumers (individuals), providers and the health systems (environment) as main dimensions according to the constructs of social cognitive theory, supported by the quantitative measures i.e., odds ratios as reported by each of the study authors. Main Results: We included 77 studies primarily describing the barriers and enablers. Most of the studies were from high income settings (72.7%, 56/77) and cross sectional in design (76.6%, 59/77). From the perspectives of consumers, lack of knowledge, attitude, awareness and motivation were identified as major barriers. The enablers were fear of blindness, proximity of screening facility, experiences of vision loss and being concerned of eye complications. In providers' perspectives, lack of skilled human resources, training programs, infrastructure of retinal imaging and cost of services were the main barriers. Higher odds of uptake of DRS services was observed when PwDM were provided health education (odds ratio (OR) 4.3) and having knowledge on DR (OR range 1.3-19.7). Conclusion: Knowing the barriers to access DRS is a pre-requisite in development of a successful screening program. The awareness, knowledge and attitude of the consumers, availability of skilled human resources and infrastructure emerged as the major barriers to access to DRS in any income setting.
Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy
ClinicalTrials.gov study NCT02834663. IPD Sharing: NO. Countries: 0. Publications: 19.
The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study (TREAT)
ClinicalTrials.gov study NCT03113006. IPD Sharing: NO. Countries: 1. Publications: 19.
Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2
ClinicalTrials.gov study NCT00763802. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Safety of Trypan Blue on Endothelium of Diabetic Retinopathy Patients
ClinicalTrials.gov study NCT03755752. IPD Sharing: NO. Countries: 1. Publications: 1.
Macular Vessels Density Before and After PRP in Patients With Proliferative Diabetic Retinopathy
ClinicalTrials.gov study NCT04976361. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Bevacizumab as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
ClinicalTrials.gov study NCT01389505. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy
ClinicalTrials.gov study NCT01976923. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Oral Diclofenac for Retinal Photocoagulation in Diabetic Retinopathy
ClinicalTrials.gov study NCT01009021. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales
ClinicalTrials.gov study NCT06914778. IPD Sharing: UNDECIDED. Countries: 1. Publications: 27.
Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone
ClinicalTrials.gov study NCT00931125. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Intelligent Evaluation of Diabetic Retinopathy
ClinicalTrials.gov study NCT04624737. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation System and Clinical Application for Diabetic Retinopathy
ClinicalTrials.gov study NCT03528720. IPD Sharing: NO. Countries: 1. Publications: 1.
Neurovascular Coupling in Patients With Early Stage Diabetes Retinopathy
ClinicalTrials.gov study NCT00712842. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Diabetic Retinopathy Sulodexide Study
ClinicalTrials.gov study NCT01295775. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.